Patients at Manchester Adult Cystic Fibrosis Centre are the first in Europe to have received the life-changing drug, Kaftrio, as part of standard NHS care.
Read more
For three-year-old Elliott, who has a rare genetic disorder, life has been transformed by taking part in a clinical trial at Manchester Clinical Research Facility (CRF).
Read more
A decade-long study has identified the factor produced by a common species of skin bacteria that triggers eczema.
Read more
More than 600 school children and teachers in Greater Manchester have taken part in a new voluntary coronavirus study, which is assessing the prevalence of COVID-19 in school pupils and teachers.
Read more
A patient at the Royal Manchester Children’s Hospital (RMCH) was the first in the UK to receive a convalescent plasma transfusion, after being selected through the RECOVERY COVID-19 research study.
Read more
Early results for a potentially revolutionary brain disease therapy given under compassionate use to a two-year-old has shown promise
Read more
Our first patient has participated in the RUXCOVID research trial, which is testing whether the drug ruxolitinib could be a potential treatment for COVID-19 (coronavirus).
Read more
